Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;30(2):91-97.
doi: 10.1055/s-0040-1714752. Epub 2020 Aug 30.

Endarterectomy for Iliac Occlusive Disease during Kidney Transplantation: A Multicenter Experience

Affiliations

Endarterectomy for Iliac Occlusive Disease during Kidney Transplantation: A Multicenter Experience

William S Sorrells et al. Int J Angiol. 2021 Jun.

Abstract

Little is known about the surgical challenges and outcomes of kidney transplantation (KT) in the face of severe iliac occlusive disease (IOD). We aim to examine our institution's experience and outcomes compared with all KT patients. Retrospective review of our multi-institutional transplant database identified patients with IOD requiring vascular surgery involvement for iliac artery endarterectomy at time of KT from 2000 to 2018. Clinical data, imaging studies, and surgical outcomes of 22 consecutive patients were reviewed. Our primary end-point was allograft survival. Secondary end-points included mortality and perioperative complications. A total of 6,757 KT were performed at our three sites (Florida, Arizona, and Minnesota); there were 22 (0.32%) patients receiving a KT with concomitant IOD requiring iliac artery endarterectomy. Mean patient age was 61.45 ± 7 years. There were 13 (59.1%) male patients. The most common etiology of renal failure was diabetic nephropathy in 10 patients (45.5%) followed by a combination of hypertensive/diabetic nephropathy in five patients (22.7%), and hypertensive nephrosclerosis in three patients (13.6%). The majority ( n = 16, 72.7%) of patients received renal allografts from deceased donors and six (27.3%) were recipients from living donors. Mean time from dialysis to transplantation was 2.9 ± 2.9 years. Mean follow-up was 3.5 ± 2.5 years. Mean length of hospital stay was 6.3 ± 4.3 days (range: 3-18 days). Graft loss within 90 days occurred in two (9.1%) patients, one due to renal vein thrombosis and another due to acute tubular necrosis. Overall allograft survival was 90.1% at 1-year and 86.4% at 3-year follow-up. Overall mortality occurred in 6 (27.3%) patients. Perioperative complications (Clavien-Dindo Grade 2-4) occurred in 13 (59.1%) patients, including 10 (45.5%) with acute blood loss anemia requiring transfusion, 2 (9.1%) reoperations for hematoma evacuation, 1 (4.5%) ischemic colitis requiring total abdominal colectomy, and 1 (4.5%) renal vein thrombosis requiring nephrectomy. IOD patients selected for KT are not common and although challenging, they have similar outcomes to our standard KT patients. The 1- and 3-year allograft survivals were 90.1 and 86.4% versus 96.0 and 90.3% in the general KT patient population. With these excellent outcomes, we recommend expanding the criteria for KT to include patients with IOD with prior vascular surgery consultation to prevent progression of IOD or prevention of wait list removal in select patients who are otherwise good candidates for KT.

Keywords: peripheral arterial disease; renal failure; transplant.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None.

Figures

Fig. 1
Fig. 1
Coronal view of a noncontrast computed tomography scan of the abdomen and pelvis in a patient with significant Iliac occlusive disease (IOD) prior to kidney transplantation.
Fig. 2
Fig. 2
Primary kidney transplantation are performed in the iliac fossa (Used with permission of Mayo Foundation for Medical Education and Research. All rights reserved).

References

    1. Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol. 2013;45(06):1605–1612. - PMC - PubMed
    1. Committee of Renal and Peripheral Arteries, Japan Atherosclerosis Society . Shoji T, Abe T, Matsuo H. Chronic kidney disease, dyslipidemia, and atherosclerosis. J Atheroscler Thromb. 2012;19(04):299–315. - PubMed
    1. Droupy S, Eschwège P, Hammoudi Y, Durrbach A, Charpentier B, Benoit G.Consequences of iliac arterial atheroma on renal transplantation J Urol 2006175(3 Pt 1):1036–1039. - PubMed
    1. Hausberg M, Kisters K, Kosch M, Barenbrock M. [Alterations of the arterial vessel wall in renal failure] Med Klin (Munich) 2000;95(05):279–285. - PubMed
    1. Kidney Transplant Working Group of the Canadian Society of Transplantation . Knoll G, Cockfield S, Blydt-Hansen T. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173(10):1181–1184. - PMC - PubMed

LinkOut - more resources